<The >role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F14%3AE0103897" target="_blank" >RIV/00843989:_____/14:E0103897 - isvavai.cz</a>
Alternative codes found
RIV/61988987:17110/14:A1501CGS
Result on the web
<a href="http://dx.doi.org/10.3109/10428194.2013.797084" target="_blank" >http://dx.doi.org/10.3109/10428194.2013.797084</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3109/10428194.2013.797084" target="_blank" >10.3109/10428194.2013.797084</a>
Alternative languages
Result language
angličtina
Original language name
<The >role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma
Original language description
Clinical outcomes for patients with multiple myeloma (MM) have improved substantially since the introduction of novel agents including the proteasome inhibitor bortezomib and the immunomodulatory drugs thalidomide and lenalidomide. However, most patientswith MM eventually relapse, and prognosis remains poor among patients with relapsed and/or refractory disease. Combination therapy using agents with different mechanisms of action is emerging as an attractive treatment approach in oncology to increase efficacy and/or overcome resistance to standard treatment regimens. This review discusses unmet needs in the treatment of MM and the development of histone deacetylase inhibitors as a treatment modality for MM.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia & lymphoma
ISSN
1042-8194
e-ISSN
—
Volume of the periodical
55
Issue of the periodical within the volume
n. 1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
8
Pages from-to
"p. 11-18"
UT code for WoS article
000329122600006
EID of the result in the Scopus database
—